Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 1Lymphoid 1

Conditions

Carcinoma, Renal Cell 4Lymphoma, Mantle-Cell 2Carcinoma 2Carcinoma, Squamous Cell 1

Interventions

temsirolimus 2Sunitinib 2Sorafenib 2Axitinib 2sonidegib 1niraparib 1lenvatinib 1gadolinium ethoxybenzyl DTPA 1donafenib 1Transurethral Resection of Prostate 1Therapeutics 1Phlebotomy 1Palliative Care 1Mitomycin 1Methylation 1Maintenance 1Interviews as Topic 1Hyperthermic Intraperitoneal Chemotherapy 1HhAntag691 1Hepatectomy 1Fatty Acids, Omega-6 1Endoscopy 1Cetuximab 1Breath Tests 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Carcinoma × temsirolimus × Clear all
NCT00700258 2024-09-23

STAR-TOR

Pfizer

Completed
1,520 enrolled 24 charts
Lymphoid

Carcinoma, Lymphoma, Mantle-Cell

NCT00195299 2007-12-27

Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck

Wyeth is now a wholly owned subsidiary of Pfizer

Completed
20 enrolled
Tumor-Agnostic

Carcinoma, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡